New sleep drug could ease both insomnia and depression
NCT ID NCT07555743
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether daridorexant, a sleep medication, can help people who have both major depression and insomnia. Researchers want to see if it improves sleep quality and also eases depressive symptoms. About 134 adults will take either daridorexant or a placebo for three months, tracking their sleep and mood through questionnaires and overnight sleep tests.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INSOMNIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitari de Bellvitge
Barcelona, Catalonia, 08908, Spain
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Light therapy during sleep may offer a Drug-Free path to better rest
- Can a structured care pathway ease teen depression?
- Can a nasal spray break through tough depression?
- Could a new drug offer hope for Treatment-Resistant depression?
- Mind over bladder: can sleep training curb nighttime urges?
- Targeting depression: can MRI-Guided brain zaps rewire key circuits?